Core Insights - Curaleaf Holdings, Inc. will participate in the 38th Annual ROTH Conference, featuring a Fireside Chat with Chairman and CEO Boris Jordan on March 24, 2026 [1][2] Company Overview - Curaleaf is a leading international provider of consumer cannabis products, focused on enhancing lives through the power of the plant [3] - The company operates under various brands, including Curaleaf, Select, Grassroots, Find, and Anthem, and is recognized for quality, expertise, and reliability in the cannabis industry [3] - Curaleaf has a strong presence across all stages of the supply chain and operates a unique distribution network in Europe, Canada, and Australasia [3] - The company is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF [3]

Core Viewpoint - Curaleaf Holdings, Inc. has announced a change in the date of its special meeting to seek shareholder approval for a proposed arrangement involving the continuation of the Company from British Columbia, Canada to Delaware, USA, aiming to enhance shareholder participation and streamline the approval process [1]. Group 1: Meeting Details - The special meeting was initially scheduled for February 23, 2026, but has been postponed to align with the annual general meeting expected in the second quarter of 2026 [1]. - The Company believes that combining the special meeting with the annual general meeting will promote greater shareholder participation and result in a more cost-effective use of resources [1]. Group 2: Company Overview - Curaleaf is a leading international provider of consumer cannabis products, known for its quality, expertise, and reliability [1]. - The Company operates under various brands, including Curaleaf, Select, Grassroots, Find, Anthem, and The Hemp Company, providing industry-leading service and product selection across medical and adult-use markets [1]. - Curaleaf has a strong presence in all stages of the supply chain and a unique distribution network throughout Europe, Canada, and Australasia [1].

Core Insights - Curaleaf Holdings, Inc. will report its financial and operating results for Q4 and the full year ended December 31, 2025, on February 26, 2026, after market close [1] - The company is a leading international provider of consumer cannabis products, emphasizing quality, expertise, and reliability [3] Financial Reporting - The earnings conference call will take place on February 26, 2026, at 5:00 p.m. ET, featuring prepared remarks and a Q&A session [2] - A dial-in replay of the conference call will be available until March 5, 2026, for those unable to attend live [2] Company Overview - Curaleaf operates under various brands, including Curaleaf, Select, Grassroots, and others, providing a wide range of products in both medical and adult-use markets [3] - Curaleaf International is noted as the largest vertically integrated cannabis company in Europe, with a strong supply and distribution network [3]

Core Viewpoint - Curaleaf Holdings, Inc. plans to seek shareholder approval for a proposed arrangement to continue its operations from British Columbia, Canada to Delaware, United States, which is expected to enhance its strategic objectives and streamline its organizational structure [1][2]. Group 1: Proposed Arrangement - The proposed arrangement includes the continuation of Curaleaf from British Columbia to Delaware, with all existing subordinate voting shares being converted to Delaware subordinate voting shares [2]. - The arrangement will not result in any material changes to the Company's business or operations [3]. Group 2: Shareholder Approval Process - Curaleaf intends to send a management information circular to shareholders and hold a special meeting on or about February 23, 2026, to seek approval for the arrangement [4]. - Approval requires a two-thirds majority (66 2/3%) of the votes cast by holders of subordinate voting shares and multiple voting shares [5]. Group 3: Implementation and Future Steps - The board of directors will determine the timing for implementing the arrangement, subject to necessary approvals, and may choose not to proceed if it is not in the best interests of the Company [6]. - After the arrangement, the Delaware subordinate voting shares are expected to continue trading on the Toronto Stock Exchange and OTCQX under the same trading symbols [7].

Core Insights - Curaleaf Holdings, Inc. has secured a significant $100 million revolving credit facility, marking the largest of its kind in the U.S. cannabis sector to date [1][2] - This financing is a pivotal advancement for institutional lending within the cannabis industry, indicating growing confidence from lenders in the sector's future [1][2] Company Overview - Curaleaf is a leading international provider of consumer cannabis products, with a mission to enhance lives through the power of the cannabis plant [3] - The company operates under various brands, including Curaleaf, Select, Grassroots, Find, Anthem, and The Hemp Company, and has a strong presence across the medical and adult-use markets [3] Financial Details - The newly amended credit facility has an initial term of one year, with an interest rate of 7.99% on outstanding principal, which can extend up to five years with a potential rate increase to 8.99% if the company refinances its Senior Note Facility due in 2026 [2] - Curaleaf plans to utilize at least $50 million from this credit facility to pay down higher interest-bearing acquisition-related debt while ensuring sufficient capacity for working capital needs [2]

Core Insights - Curaleaf Holdings, Inc. will report its financial and operating results for the third quarter ended September 30, 2025, after market close on November 5, 2025 [1] - A conference call and audio webcast will be held on the same day at 5:00 p.m. ET to discuss the Company's operational and financial highlights [2] Company Overview - Curaleaf is a leading international provider of consumer cannabis products, with a mission to enhance lives through the power of the plant [3] - The Company is recognized for its high growth, quality, expertise, and reliability, offering a wide range of products and services across medical and adult-use markets [3] - Curaleaf operates a strong distribution network in Europe, Canada, and Australasia, integrating science and research with advanced cultivation, extraction, and production techniques [3]

Industry Overview - The U.S. cannabis industry is experiencing significant growth, with legal sales surpassing $33 billion in 2024 and projected revenues of $50 billion by 2030 [1][3] - Expansion into new adult-use markets and growth in medical programs are creating new opportunities [1][3] - Federal rescheduling and potential banking reforms are increasing optimism in the sector [1][2] Key Companies - Trulieve Cannabis Corp. operates 231 retail dispensaries and has a strong presence in Florida, with a cultivation and processing footprint of over four million square feet [4][7] - Curaleaf Holdings, Inc. operates in 19 states with 154 retail dispensaries and has recently consolidated its international business, enhancing its global position [8][10] - Green Thumb Industries, Inc. operates over 101 retail locations and 20 manufacturing facilities, focusing on both adult-use and medical markets [12][14] Financial Performance - Trulieve reported $302 million in revenue for Q2 2025, with a gross margin of 61% and adjusted EBITDA of $111 million [7][15] - Curaleaf's Q2 2025 net revenue was $314.5 million, an 8% decline from the previous year, with a gross margin of 49% [10][11] - Green Thumb Industries reported Q2 2025 revenue of $293.3 million, a 4.7% increase year-over-year, with a gross margin of 49.9% [14][15] Market Positioning - Trulieve is recognized for its retail penetration and product distribution, supported by a large loyalty program with over 725,000 members [4][7] - Curaleaf's extensive retail and wholesale network positions it well for continued expansion, despite recent revenue challenges [8][11] - Green Thumb's strategy combines brand development with an expanding retail footprint, contributing to steady sales growth [12][14] Investment Considerations - The cannabis sector remains volatile, necessitating careful technical analysis and disciplined risk management for traders [1][2] - Companies with strong fundamentals and expanding footprints are likely to benefit from ongoing industry developments [2][15] - Investors are advised to monitor technical setups while applying risk management strategies to navigate the market effectively [16]